You are here

Management of Patients under Radiotherapy: oral mucositis

By Joel Epstein, recorded at TAO (Transatlantic Oncology meeting), Nov 20-21, 2014, Paris

8 - Joel Epstein ANG

The true incidence of oral mucositis is underestimated, as most patients only report it when asked directly. Joel Epstein discusses why mucositis matters in the treatment of a potentially fatal disease. Mucositis is a common and debilitating condition which causes pain, affects oral function and leads to acute and/or chronic complications such as stomatitis, alterations in taste perception and saliva production, tissue necrosis, caries, etc. This can result, for example, in dehydration, weight loss or an increased use of analgetics. As a result, it may be necessary to reduce or discontinue the cancer treatment or hospitalise the patient, which has a major impact on the completion of cancer therapy, affects the patient’s quality of life and leads to increased costs.


Joel Epstein, City of Hope Cancer Center, San Francisco, USA

Search this site

Featured videos

Free access to ebooks on cachexia and CINV


Prevention of nausea and vomiting in
adult cancer patients receiving tumour-
directed therapy – 2017 update –

Cancer cachexia: mechanisms and progress in treatment


Stay up-to-date with our monthly e-alert

If you want to regularly receive information on what is happening in Quality of Life in Oncology research sign up to our e-alert.

Subscribe »

QOL (Quality of Life) newsletter e-alert

Quality of Life promotional video

Made possible by an educational grant from Helsinn

Helsinn does not have any influence on the content and all items are subject to independent peer and editorial review

Society Partners

European Cancer Organisation Logo